Phebra Pharma
Australian manufacturer of critical care sterile injectables and specialty medicines with a 65‑product portfolio.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
AI Company Overview
Australian manufacturer of critical care sterile injectables and specialty medicines with a 65‑product portfolio.
Critical CareOphthalmologyCardiologyInfectious DiseasesAnesthesiology
Technology Platform
High‑quality sterile injectable manufacturing with aseptic filling, lyophilisation, and advanced formulation capabilities, supported by GMP‑compliant, energy‑efficient processes.
Opportunities
Expansion of out‑licensing agreements and export markets, plus potential entry into biologics manufacturing and sustainable production technologies.
Risk Factors
Regulatory compliance challenges, competition from larger contract manufacturers, and supply‑chain disruptions for critical raw materials.
Competitive Landscape
Competes with regional contract manufacturers such as CSL, Mayne Pharma, and global players like Pfizer's CMOs; differentiation comes from its Australian base, sustainability focus, and niche critical‑care product portfolio.